Journal of the American Society of Nephrology
2008 JASN IMPACT FACTOR 7.505 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


Published ahead of print on October 17, 2007
Journal of the American Society of Nephrology
© 2007 American Society of Nephrology
doi: 10.1681/ASN.2007010119
This Article
Right arrow Full Text (Rapid PDF)
Right arrow All Versions of this Article:
ASN.2007010119v1
18/11/2885    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Singh, A.
Right arrow Articles by Mathieson, P. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Singh, A.
Right arrow Articles by Mathieson, P. W.
Related Collections
Right arrowRelated Article

Received January 28, 2007
Accepted on June 18, 2007

BASIC RESEARCH: Basic Research

Glomerular Endothelial Glycocalyx Constitutes a Barrier to Protein Permeability

Anurag Singh *1, Simon C. Satchell *, Chris R. Neal {dagger}, Edward A. McKenzie {ddagger}, John E. Tooke {sect}, and Peter W. Mathieson *

*Academic Renal Unit, Southmead Hospital, and {dagger}Microvascular Research Laboratories, University of Bristol, {ddagger}Faculty of Life Sciences, Michael Smith Building, University of Manchester, Manchester, and {sect}Department of Vascular Medicine and Diabetes Research, Peninsula Medical School, University of Exeter, Exeter, United Kingdom


*Academic Renal Unit, Southmead Hospital, and {dagger}Microvascular Research Laboratories, University of Bristol, {ddagger}Faculty of Life Sciences, Michael Smith Building, University of Manchester, Manchester, and {sect}Department of Vascular Medicine and Diabetes Research, Peninsula Medical School, University of Exeter, Exeter, United Kingdom


1 To whom correspondence should be addressed. E-mail: Anurag.Singh{at}bristol.ac.uk.


   Abstract

Glycocalyx, composed of glycoproteins including proteoglycans, coats the luminal surface of the glomerular capillaries. Human heparanase degrades heparan sulphate glycosaminoglycans and is up-regulated in proteinuric states. In this study, we analyze the structure of the human glomerular endothelial cell glycocalyx in vitro and examine its functional relevance, especially after treatment with human heparanase. Electron microscopy of conditionally immortalized glomerular endothelial cells revealed a 200-nm thick glycocalyx over the plasma membrane, which was also demonstrated by confocal microscopy. Neuraminidase treatment removed the majority of glycocalyx, reduced trans-endothelial electrical resistance by 59%, and increased albumin flux by 207%. Heparinase III and human heparanase specifically cleaved heparan sulphate: this caused no change in trans-endothelial electrical resistance, but increased the albumin passage across the monolayers by 40% and 39%, respectively. Therefore, we have characterized the glomerular endothelial cell glycocalyx and have shown that it contributes to the barrier to flux of albumin across the cell layer. These results suggest an important role for this glycocalyx in the restriction of glomerular protein passage in vivo and suggest ways in which human heparanase levels may be linked to proteinuria in clinical disease.


Related Article

This Month’s Highlights
J. Am. Soc. Nephrol. 2007 18: F3. [Full Text] [PDF]



This article has been cited by other articles:


Home page
Nephrol Dial TransplantHome page
N. P. J. Vogtlander, J. van der Vlag, M. A. H. Bakker, H. B. Dijkman, R. A. Wevers, K. P. Campbell, J. F. M. Wetzels, and J. H. M. Berden
Expression of sialidase and dystroglycan in human glomerular diseases
Nephrol. Dial. Transplant., September 15, 2009; (2009) gfp465v1.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
A. H.J. Salmon, C. R. Neal, L. M. Sage, C. A. Glass, S. J. Harper, and D. O. Bates
Angiopoietin-1 alters microvascular permeability coefficients in vivo via modification of endothelial glycocalyx
Cardiovasc Res, July 1, 2009; 83(1): 24 - 33.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
S. C. Satchell and F. Braet
Glomerular endothelial cell fenestrations: an integral component of the glomerular filtration barrier
Am J Physiol Renal Physiol, May 1, 2009; 296(5): F947 - F956.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
R. Lennon, A. Singh, G. I. Welsh, R. J. Coward, S. Satchell, L. Ni, P. W. Mathieson, W. W. Bakker, and M. A. Saleem
Hemopexin Induces Nephrin-Dependent Reorganization of the Actin Cytoskeleton in Podocytes
J. Am. Soc. Nephrol., November 1, 2008; 19(11): 2140 - 2149.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
K. Ichimura, R. V. Stan, H. Kurihara, and T. Sakai
Glomerular Endothelial Cells Form Diaphragms during Development and Pathologic Conditions
J. Am. Soc. Nephrol., August 1, 2008; 19(8): 1463 - 1471.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
O. Devuyst and E. Goffin
Water and solute transport in peritoneal dialysis: models and clinical applications
Nephrol. Dial. Transplant., July 1, 2008; 23(7): 2120 - 2123.
[Full Text] [PDF]




HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP